We previously reported that 211At-sodium astatide ([211At]NaAt) is taken up by differentiated thyroid cancer cells via the sodium-iodide symporter (NIS), similar to iodine (Watabe et al. 2019, 2022). The gene discussed is SLC5A5; the disease is thyroid cancer.